-
1
-
-
0036468440
-
CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: Results of a phase II study
-
Ajani J A, Baker J, Pisters PW, et al. CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study. Cancer, 2002, 94(3):641.
-
(2002)
Cancer
, vol.94
, Issue.3
, pp. 641
-
-
Ajani, J.A.1
Baker, J.2
Pisters, P.W.3
-
2
-
-
0037560302
-
Phase II trial of irinotecan (CPT-11) in relapsed or refractory non-Hodgkin' s lymphomas
-
Ribrag V, Koscielny S, Vantelon JM, et al. Phase II trial of irinotecan (CPT-11) in relapsed or refractory non-Hodgkin' s lymphomas. Leuk Lymphoma, 2003, 44(9):1529.
-
(2003)
Leuk Lymphoma
, vol.44
, Issue.9
, pp. 1529
-
-
Ribrag, V.1
Koscielny, S.2
Vantelon, J.M.3
-
3
-
-
33751270901
-
-
Chinese source
-
-
-
-
4
-
-
0031984916
-
Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase
-
Zhang R, Li Y, Cai Q, et al. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase. Cancer Chemother Pharmacol, 1998, 41:257.
-
(1998)
Cancer Chemother Pharmacol
, vol.41
, pp. 257
-
-
Zhang, R.1
Li, Y.2
Cai, Q.3
-
5
-
-
33751282201
-
-
Chinese source
-
-
-
-
6
-
-
0035116969
-
Prospective phase II trial of iriontecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer
-
Gil-Delgado M A, Guinet F, Castaing D, et al. Prospective phase II trial of iriontecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer. Am J Clin Oncol, 2001, 24(1):101.
-
(2001)
Am J Clin Oncol
, vol.24
, Issue.1
, pp. 101
-
-
Gil-Delgado, M.A.1
Guinet, F.2
Castaing, D.3
-
7
-
-
13744262395
-
A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPTIl) in previously pretreated metastatic colorectal cancer patients
-
Louvet C, Andre T, Gamelin E, et al. A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPTIl) in previously pretreated metastatic colorectal cancer patients. Bull Cancer, 2004, 91(12):279.
-
(2004)
Bull Cancer
, vol.91
, Issue.12
, pp. 279
-
-
Louvet, C.1
Andre, T.2
Gamelin, E.3
-
8
-
-
33751267241
-
-
Chinese source
-
-
-
-
9
-
-
0035735324
-
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy
-
Witkamp A J, Bree E D, Goethem A R V, et al. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev, 2001, 27(6):365.
-
(2001)
Cancer Treat Rev
, vol.27
, Issue.6
, pp. 365
-
-
Witkamp, A.J.1
Bree, E.D.2
Goethem, A.R.V.3
-
10
-
-
0037363051
-
Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study
-
Glehen O, Mithieux F, Osinsky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol, 2003, 21(5):799.
-
(2003)
J Clin Oncol
, vol.21
, Issue.5
, pp. 799
-
-
Glehen, O.1
Mithieux, F.2
Osinsky, D.3
-
11
-
-
4744339834
-
Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer
-
Yano M, Yasuda T, Fujiwara Y, et al. Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer. J Surg Oncol, 2004, 88(1):39.
-
(2004)
J Surg Oncol
, vol.88
, Issue.1
, pp. 39
-
-
Yano, M.1
Yasuda, T.2
Fujiwara, Y.3
-
12
-
-
2942585119
-
Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer
-
Yonemura Y, Endou Y, Bando E, et al. Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. Cancer Lett, 2004, 210(2):189.
-
(2004)
Cancer Lett
, vol.210
, Issue.2
, pp. 189
-
-
Yonemura, Y.1
Endou, Y.2
Bando, E.3
|